You just read:

Chondrial Therapeutics Secures Up to $22.6 Million in Series A Financing and Licenses Novel Technology for the Treatment of Friedreich's Ataxia

News provided by

Chondrial Therapeutics, Inc.

Feb 06, 2017, 08:02 ET